THE EFFECTS OF COMMUNITY-BASED PHARMACEUTICAL CARE SERVICES ON ASTHMA-RELATED QUALITY OF LIFE

Author(s)

Boyd BJ, Rascati, KL, Lawson, KA, The University of Texas at Austin College of Pharmacy, Austin, TX, USA

Community pharmacy practice is evolving from a product-oriented focus to an environment where pharmaceutical care services are provided in order to meet an overall therapeutic goal (disease management). Specialized services may contribute to positive therapeutic outcomes for patients served and may improve patients' quality of life. OBJECTIVE: The purpose of this study was to determine the effects of specialized pharmaceutical care services for adult asthmatic patients served in community pharmacy settings on their health-related quality of life. METHOD: Adult asthmatic patients received specialized pharmaceutical services for one year in 7 community pharmacies located throughout Texas. All intervention pharmacies were members of a pharmaceutical care network that provided software, enabling pharmacists to document interactions with patients. All study patients were insured by Blue Cross/Blue Shield of Texas, patronized an intervention pharmacy, were confirmed asthmatics (by their physician), and were currently taking asthma medication(s). Juniper's Asthma Quality of Life Questionnaire, which includes activity, symptom, emotion, and exposure domains, was used to evaluate quality of life changes. RESULTS: A total of 25 patients completed quality of life questionnaires over the course of the intervention period and had pharmacist documentation. Quality of life scores were compared before and during intervention periods. When mean baseline overall quality of life scores were compared to mean ending overall quality of life scores for intervention patients, a statistically significant improvement was found (t = -2.872; df = 20; p = 0.009). Statistically significant improvements were also observed in the activity (t = -2.795; df = 20; p = 0.011) and symptom (t = -2.913; df = 20; p = 0.009) domains. CONCLUSIONS: While improved quality of life was associated with the pharmaceutical care intervention, further research involving more patients is needed to adequately determine the extent of benefits that specialized pharmaceutical care services could provide.

Conference/Value in Health Info

1998-05, ISPOR 1998, Philadelphia, PA, USA

Value in Health, Vol. 1, No. 1 (May/June 1998)

Code

PGD1

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×